Eocene (EOCN) vs GRI Bio (GRI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Eocene is the larger company by market cap ($3.9 million vs $3.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EOCN | GRI |
|---|---|---|
| Share price | $3.62 | $1.68 |
| Market cap | $3.87M | $3.67M |
| 1-day change | +4.69% | -9.19% |
| EPS (TTM) | $-15.21 | $-13.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.80 | $64.12 |
| 52-week low | $3.12 | $1.36 |
| Distance from 52-week high | -71.72% | -97.38% |
| Analyst consensus | none | none |
| Avg. price target upside | — | +1001.19% |
| Average volume | 59.85K | 328.06K |
| Shares outstanding | 1.07M | 2.19M |
| Employees | 3 | 3 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Eocene
EOCN stock →Eocene Ltd. a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications.
Healthcare · Biotechnology · 3 employees
About GRI Bio
GRI stock →GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis.
Healthcare · Biotechnology · 3 employees
EOCN vs GRI FAQ
Which is bigger, Eocene or GRI Bio?
Eocene (EOCN) is larger, with a market capitalization of $3.87M compared with $3.67M for GRI Bio (GRI).
Are Eocene and GRI Bio in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.